Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers

The treatment response in chronic pulmonary aspergillosis (CPA) is usually assessed based on the improvement in clinical and imaging findings. Herein, we evaluate serum Aspergillus fumigatus-specific IgG, serum galactomannan, weight change, and lung function for assessing treatment response in subje...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology and infection 2019-09, Vol.25 (9), p.1157.e1-1157.e7
Hauptverfasser:	Sehgal, I.S., Dhooria, S., Choudhary, H., Aggarwal, A.N., Garg, M., Chakrabarti, A., Agarwal, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Fungal - blood Antifungal Agents - therapeutic use Aspergillosis Azoles - therapeutic use Body Weight Bronchoalveolar lavage Chronic Disease CPA ELISA Female Follow-Up Studies Galactomannan Humans ImmunoCap Immunoglobulin G - blood Lung - physiology Male Mannans - blood Middle Aged Prospective Studies Pulmonary Aspergillosis - blood Pulmonary Aspergillosis - drug therapy Pulmonary Aspergillosis - immunology Pulmonary Aspergillosis - physiopathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!